Head-to-Head Startup Ranking & Discovery
GGranza Bio logo

Granza Bio

Bio · US · Early-stage
granzabio.com
Synthetic BiologyBiotechHealthcareTherapeuticsOncology

Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.

Founded
2024
Headquarters
San Francisco, CA, USA
Team size
1–10
Stage
Early-stage
📊 Coliseo ratings
🏆 Overall 1472 Elo
1478
💰 Conviction
Provisional
1462
🔥 Momentum
Provisional
1475
🧲 Talent
Provisional
Total matchups0
⚔️ Vote on today's matchups →

Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →